Phibro Animal Health (PAHC) Operating Income Growth (3y) (2015 - 2026)
Phibro Animal Health (PAHC) Operating Income Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 40.17% |
| 10 | Phibro Animal Health | 1.41 Bn | 1.33 Bn | 125.68 Mn | 34.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.01% |
| Dec 31, 2025 | 47.00% |
| Sep 30, 2025 | 55.31% |
| Jun 30, 2025 | 13.79% |
| Mar 31, 2025 | 20.42% |
| Dec 31, 2024 | 4.63% |
| Sep 30, 2024 | 6.60% |
| Jun 30, 2024 | -1.31% |
| Mar 31, 2024 | -0.35% |
| Dec 31, 2023 | -7.58% |
| Sep 30, 2023 | -26.96% |
| Jun 30, 2023 | 9.46% |
| Mar 31, 2023 | -4.53% |
| Dec 31, 2022 | -6.86% |
| Sep 30, 2022 | 10.48% |
| Jun 30, 2022 | 23.67% |
| Mar 31, 2022 | -5.25% |
| Dec 31, 2021 | -4.64% |
| Sep 30, 2021 | -13.85% |
| Jun 30, 2021 | -9.80% |